Last reviewed · How we verify

NCT04803825

The NOrwegian Tennis Elbow (NOTE) Study

Completed NA Last updated 5 March 2024
What this trial tests

NA trial testing Heavy Slow Exercises in Lateral Epicondylitis in 100 participants. Completed in 20 December 2023.

Timeline
23 August 2021
Primary endpoint
13 September 2023
20 December 2023

Quick facts

Lead sponsorOslo University Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment100
Start date23 August 2021
Primary completion13 September 2023
Estimated completion20 December 2023
Sites1 location across Norway

Drugs / interventions tested

Conditions studied

Sponsor

Oslo University Hospital

Who can join

Adults 18 to 100, any sex, with Lateral Epicondylitis or Tennis Elbow. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Trial Design: The Norwegian Tennis Elbow (NOTE) study is a single-centre; three-armed, feasibility randomised controlled trial. Aim: The primary aim of this study is to pilot the methods proposed to conduct a definite RCT study. Objectives: * Measure the process of recruitment. * Measure intervention adherence and acceptability. * Measure outcome measure retention rate and completeness. The Patient-Rated Tennis Elbow Evaluation (PRTEE) will be used as the primary outcome measure. Intervention: Patients will be randomised to either: 1) Heavy slow resistance training (HSR), 2) Radial extracorporeal shock wave therapy (rESWT) or 3) Information and advice. Follow-up will be after 3 and 6 months.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Manual therapy and exercise for lateral elbow pain.
    Wallis JA, Bourne AM, Jessup RL, Johnston RV, et al · · 2024 · cited 7× · PMID 38802121 · DOI 10.1002/14651858.cd013042.pub2
  2. Heavy slow resistance training, radial extracorporeal shock wave therapy or advice for patients with tennis elbow in the Norwegian secondary care: a randomised controlled feasibility trial.
    Sveinall H, Brox JI, Engebretsen KB, Hoksrud AF, et al · · 2024 · cited 1× · PMID 39806585 · DOI 10.1136/bmjopen-2024-085916
  3. Measurement properties of core outcomes in patients with tennis elbow.
    Sveinall H, Brox JI, Engebretsen KB, Hoksrud AF, et al · · 2025 · PMID 40453542 · DOI 10.1177/17585732251344264

Verify or expand the search:

Other recruiting trials for Lateral Epicondylitis

Currently open trials in the same condition.

Other Oslo University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04803825.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing